Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1983-3-11
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
10 Suppl C
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
45-50
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:6296028-Anaerobiosis,
pubmed-meshheading:6296028-Bacteria,
pubmed-meshheading:6296028-Bacteroides,
pubmed-meshheading:6296028-Bacteroides fragilis,
pubmed-meshheading:6296028-Cefotaxime,
pubmed-meshheading:6296028-Ceftizoxime,
pubmed-meshheading:6296028-Cephalosporins,
pubmed-meshheading:6296028-Clostridium perfringens
|
pubmed:year |
1982
|
pubmed:articleTitle |
In-vitro activity of ceftizoxime against anaerobic bacteria and comparison with other cephalosporins.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|